BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12956424)

  • 1. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.
    Hapke S; Kessler H; Luber B; Benge A; Hutzler P; Höfler H; Schmitt M; Reuning U
    Biol Chem; 2003 Jul; 384(7):1073-83. PubMed ID: 12956424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
    Lössner D; Abou-Ajram C; Benge A; Reuning U
    Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
    Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription.
    Lössner D; Abou-Ajram C; Benge A; Aumercier M; Schmitt M; Reuning U
    J Cell Physiol; 2009 Aug; 220(2):367-75. PubMed ID: 19334037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
    Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
    Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin αvβ3 promotes vitronectin gene expression in human ovarian cancer cells by implicating rel transcription factors.
    Reuning U
    J Cell Biochem; 2011 Jul; 112(7):1909-19. PubMed ID: 21433063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin.
    Janik ME; Przybyło M; Pocheć E; Pokrywka M; Lityńska A
    Acta Biochim Pol; 2010; 57(1):55-61. PubMed ID: 20066177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway.
    Zheng DQ; Woodard AS; Fornaro M; Tallini G; Languino LR
    Cancer Res; 1999 Apr; 59(7):1655-64. PubMed ID: 10197643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line.
    Santoni G; Spreghini E; Lucciarini R; Amantini C; Piccoli M
    Microb Pathog; 2001 Oct; 31(4):159-72. PubMed ID: 11562169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 3 integrin phosphorylation is essential for Arp3 organization into leukocyte alpha V beta 3-vitronectin adhesion contacts.
    Chandhoke SK; Williams M; Schaefer E; Zorn L; Blystone SD
    J Cell Sci; 2004 Mar; 117(Pt 8):1431-41. PubMed ID: 14996908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
    Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
    Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells.
    Urbinati C; Bugatti A; Giacca M; Schlaepfer D; Presta M; Rusnati M
    J Cell Sci; 2005 Sep; 118(Pt 17):3949-58. PubMed ID: 16105876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3.
    Cheng SL; Lai CF; Blystone SD; Avioli LV
    J Bone Miner Res; 2001 Feb; 16(2):277-88. PubMed ID: 11204428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion.
    Beck V; Herold H; Benge A; Luber B; Hutzler P; Tschesche H; Kessler H; Schmitt M; Geppert HG; Reuning U
    Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface overexpression of alphavbeta5 integrin impedes alphavbeta3-mediated migration of the human ovarian adenocarcinoma cell line IGROV1.
    Maubant S; Leroy-Dudal J; Carreiras F; Deslandes E; Duigou F; Staedel C; Gauduchon P
    Cell Biol Int; 2007 Feb; 31(2):109-18. PubMed ID: 17074516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
    Hall H; Djonov V; Ehrbar M; Hoechli M; Hubbell JA
    Angiogenesis; 2004; 7(3):213-23. PubMed ID: 15609076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ovarian adenocarcinoma cells synthesize vitronectin and use It to organize their adhesion.
    Carreiras F; Cruet S; Staedel C; Sichel F; Gauduchon P
    Gynecol Oncol; 1999 Mar; 72(3):312-22. PubMed ID: 10053101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific.
    Naik MU; Naik UP
    J Cell Sci; 2006 Feb; 119(Pt 3):490-9. PubMed ID: 16418218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via alpha(v)beta(5) integrin.
    Takahashi T; Suzuki K; Ihara H; Mogami H; Kazui T; Urano T
    Semin Thromb Hemost; 2005 Jun; 31(3):356-63. PubMed ID: 16052409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin.
    Klausen C; Leung PC; Auersperg N
    Mol Cancer Res; 2009 Sep; 7(9):1425-37. PubMed ID: 19723874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.